Uncertainty-Aware Brain-Tumor Type Classification From MRI: Segmentation-Guided ROI, Conformal Prediction, and Selective Abstention Under Distribution Shift
An uncertainty-aware classification framework is presented that couples segmentation-guided region-of-interest (ROI) localization with post-hoc calibration, split-conformal prediction, and selective abstention, and a deferral rule that abstains on unreliable inputs.
Abstract
Reliable classification of brain-tumor type from magnetic resonance imaging (MRI) is essential for treatment planning and patient management. While deep neural networks achieve high accuracy on this task, they typically produce point predictions without a measure of reliability, and their confidence need not fall when image quality departs from the training distribution. An uncertainty-aware classification framework is presented that couples segmentation-guided region-of-interest (ROI) localization with post-hoc calibration, split-conformal prediction, and selective abstention: a U-Net localizes the tumor; the cropped region is classified; and the prediction is equipped with a calibrated confidence, a conformal set with a distribution-free coverage guarantee, and a deferral rule that abstains on unreliable inputs. All experiments used the Figshare brain-tumor dataset under leakage-free patient-level cross-validation. ROI localization improved patient-level balanced accuracy from 93.8% to 96.1% with a predicted mask while also improving calibration, and the 90% conformal coverage held under deployment with a predicted mask. Under bias-field, blur, and gamma corruptions, where exchangeability no longer holds, the empirical coverage degraded but was restored by recalibration and patient-aware inference, while the abstention rate rose with severity. The exchangeable unit for a valid guarantee is shown to be the patient, not the slice: slice-level calibration met the intended per-patient coverage in only 27% of resampled splits, versus 84% for patient-level calibration. The reliability layer further transfers to a four-class benchmark that adds healthy scans.
Background: Automated brain-MRI analysis is usually judged by accuracy at a single operating point, yet a model that is accurate on average may still fail without signalling that it is about to fail. Selective prediction addresses this by allowing a model to abstain, but the resulting trade-off between coverage and ris...
Accurate brain tumor localization and tumor/non-tumor classification from multimodal magnetic resonance imaging (MRI) remain challenging because standalone segmentation and classification models provide complementary but limited information for comprehensive tumor analysis. To address this limitation, a hybrid deep l...
D. M., D. Edla, A. Singh et al.· Evolutionary Bioinformatics· 0 citations
Brain tumor MRI classification models can achieve high aggregate accuracy, but reliable decision support also requires calibrated confidence estimates, transparent handling of uncertain cases, and careful evaluation under external data shift. This study presents SYNAPSE-X, a calibration-aware Vision Transformer framewo...
Sadaf Tabatabaee, M. Khasawneh· Neural computing & applicati...· 0 citations
Accurate classification and segmentation of brain tumors from Magnetic Resonance Imaging (MRI) are essential for early diagnosis, treatment planning, and clinical decision-making. However, manual interpretation of MRI scans is time-consuming and prone to inter-observer variability. Deep learning techniques have emerged...
Rashmitha R. Nayak, Ramyashree, S. Raghavendra et al.· Discover Artificial Intellig...· 0 citations
PURPOSE
Despite remarkable auto-segmentation performance and growing clinical adoption, models frequently fail to generalize beyond the training distribution. Therefore, this study aimed to develop and validate an uncertainty-aware segmentation pipeline that yields high delineation accuracy for liver cancer patients an...
D. Langner, C. Gani, S. Boeke et al.· Radiotherapy and Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.